508 related articles for article (PubMed ID: 30101710)
1. Ezrin Expression is Increased During Disease Progression in a Tauopathy Mouse Model and Alzheimer's Disease.
Vega IE; Umstead A; Wygant CM; Beck JS; Counts SE
Curr Alzheimer Res; 2018; 15(12):1086-1095. PubMed ID: 30101710
[TBL] [Abstract][Full Text] [Related]
2. A novel calcium-binding protein is associated with tau proteins in tauopathy.
Vega IE; Traverso EE; Ferrer-Acosta Y; Matos E; Colon M; Gonzalez J; Dickson D; Hutton M; Lewis J; Yen SH
J Neurochem; 2008 Jul; 106(1):96-106. PubMed ID: 18346207
[TBL] [Abstract][Full Text] [Related]
3. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
4. Amphiphysin-1 protein level changes associated with tau-mediated neurodegeneration.
De Jesús-Cortés HJ; Nogueras-Ortiz CJ; Gearing M; Arnold SE; Vega IE
Neuroreport; 2012 Nov; 23(16):942-6. PubMed ID: 22975846
[TBL] [Abstract][Full Text] [Related]
5. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
Menuet C; Borghgraef P; Matarazzo V; Gielis L; Lajard AM; Voituron N; Gestreau C; Dutschmann M; Van Leuven F; Hilaire G
Respir Physiol Neurobiol; 2011 Sep; 178(2):290-303. PubMed ID: 21763469
[TBL] [Abstract][Full Text] [Related]
6. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
7. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.
Vega IE; Cui L; Propst JA; Hutton ML; Lee G; Yen SH
Brain Res Mol Brain Res; 2005 Aug; 138(2):135-44. PubMed ID: 15913839
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy.
Bhaskar K; Hobbs GA; Yen SH; Lee G
Neuropathol Appl Neurobiol; 2010 Oct; 36(6):462-77. PubMed ID: 20609109
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy.
Berger Z; Roder H; Hanna A; Carlson A; Rangachari V; Yue M; Wszolek Z; Ashe K; Knight J; Dickson D; Andorfer C; Rosenberry TL; Lewis J; Hutton M; Janus C
J Neurosci; 2007 Apr; 27(14):3650-62. PubMed ID: 17409229
[TBL] [Abstract][Full Text] [Related]
10. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
[TBL] [Abstract][Full Text] [Related]
11. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration.
Kulic L; Wollmer MA; Rhein V; Pagani L; Kuehnle K; Cattepoel S; Tracy J; Eckert A; Nitsch RM
Neurobiol Aging; 2011 Oct; 32(10):1827-38. PubMed ID: 19942317
[TBL] [Abstract][Full Text] [Related]
12. Upper airway dysfunction of Tau-P301L mice correlates with tauopathy in midbrain and ponto-medullary brainstem nuclei.
Dutschmann M; Menuet C; Stettner GM; Gestreau C; Borghgraef P; Devijver H; Gielis L; Hilaire G; Van Leuven F
J Neurosci; 2010 Feb; 30(5):1810-21. PubMed ID: 20130190
[TBL] [Abstract][Full Text] [Related]
13. The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Soler H; Dorca-Arévalo J; González M; Rubio SE; Ávila J; Soriano E; Pascual M
Neurobiol Aging; 2017 Jan; 49():40-51. PubMed ID: 27743524
[TBL] [Abstract][Full Text] [Related]
14. Tau Proteins and Tauopathies in Alzheimer's Disease.
Chong FP; Ng KY; Koh RY; Chye SM
Cell Mol Neurobiol; 2018 Jul; 38(5):965-980. PubMed ID: 29299792
[TBL] [Abstract][Full Text] [Related]
15. Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Aβ and tau pathology in transgenic mouse models of Alzheimer's disease.
Shao CY; Mirra SS; Sait HB; Sacktor TC; Sigurdsson EM
Acta Neuropathol; 2011 Sep; 122(3):285-92. PubMed ID: 21630115
[TBL] [Abstract][Full Text] [Related]
16. Tauopathy: A common mechanism for neurodegeneration and brain aging.
Saha P; Sen N
Mech Ageing Dev; 2019 Mar; 178():72-79. PubMed ID: 30668956
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease.
Sui X; Ren X; Huang P; Li S; Ma Q; Ying M; Ni J; Liu J; Yang X
J Alzheimers Dis; 2014; 40(3):575-86. PubMed ID: 24496070
[TBL] [Abstract][Full Text] [Related]
18. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
19. Common mouse models of tauopathy reflect early but not late human disease.
Wenger K; Viode A; Schlaffner CN; van Zalm P; Cheng L; Dellovade T; Langlois X; Bannon A; Chang R; Connors TR; Oakley D; Renard B; Rappsilber J; Hyman B; Steen H; Steen JA
Mol Neurodegener; 2023 Feb; 18(1):10. PubMed ID: 36732784
[TBL] [Abstract][Full Text] [Related]
20. The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy.
Siman R; Cocca R; Dong Y
PLoS One; 2015; 10(11):e0142340. PubMed ID: 26540269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
